Bioavailability of KBP-5074 Tablet vs Capsule Formulations

NCT03340753 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: KBP-5074 Capsule
DRUG: KBP-5074 Tablet

Sponsor

KBP Biosciences

Collaborators

[object Object]